MENINGITIS B Clinical Trials

3 clinical trials for MENINGITIS B across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DOMONSTRATE EFFECTIVENESS, IMMUNOGENICITY AND SAFETY OF GSK'S MENINGOCOCCAL GROUP B AND COMBINED ABCWY VACCINES WHEN ADMINISTERED TO HEALTHY ADOLESCENTS AND YOUNG ADULTS — RECRUITING · PHASE3
• A PHASE 3B, OPEN LABEL, CONTROLLED, MULTI CENTER, EXTENSION STUDY TO ASSESS THE PERSISTENCE OF BACTERICIDAL ACTIVITY AT 4 TO 7.5 YEARS AFTER TWO DOSE PRIMARY SERIES OF NOVARTIS MENINGOCOCCAL B RECOMBINANT VACCINE AND THE RESPONSE TO A THIRD DOSE IN ADOLESCENTS AND YOUNG ADULT SUBJECTS WHO PREVIOUSLY PARTICIPATED IN PARENT STUDIES V72_41 AND V72PI0, COMPARED TO NAIVE HEALTHY CONTROLS — RECRUITING · PHASE3
• "IMMUNOGENICITY AND SAFETY STUDY OF 1 AND 2 DOSES OF GSK BIOLOGICALS' MENINGOCOCCAL VACCINE GSK134612 IN TODDLERS, PERSISTANCE UP TO 5 YEARS AFTER VACCINATION AND CO-ADMINISTRATION WITH PFIZER'S PNEUMOCOCCAL VACCINE PREVENAR 13." — RECRUITING

Refine this search